HCPLive

MARCH 27, 2024

A new analysis summarized evidence on the effects of allogeneic HSCT on SCD-related organ dysfunction in pediatric and adult patients with SCD.

Sickle Cell Disease 97

Sickle Cell Disease Pediatrics 97

HCPLive

FEBRUARY 16, 2024

Over the study period, pain screening procedures were integrated within routine clinical visits and providers’ workflow in sickle cell disease care.

Sickle Cell Disease 52

Sickle Cell Disease Pediatrics 52

DAIC

MARCH 6, 2024

Food and Drug Adminstration (FDA) has approved DEFINITY (Perflutren Lipid Microsphere) as an ultrasound enhancing agent for use in pediatric patients with suboptimal echocardiograms, including those who have undergone heart transplant, or have Kawasaki disease or a congenital cardiovascular anomaly. Lantheus announced that the U.S.

Pediatrics 105

Pediatrics Ultrasound Heart Transplant Echocardiogram 105

HCPLive

FEBRUARY 20, 2024

Voxelotor decreases oxygen extraction fraction and cerebral blood flow towards levels observed in healthy children.

Sickle Cell Disease 59

Sickle Cell Disease Pediatrics 59

HCPLive

FEBRUARY 26, 2024

An ancillary study of the phase 2 HOPE-KIDS 1 trial revealed voxelotor is associated with reduced sickling and hemolysis in children with SCD.

Sickle Cell Disease 59

Sickle Cell Disease Pediatrics 59

HCPLive

APRIL 9, 2024

A systematic review and meta-analysis of HSCT in children with sickle cell disease demonstrated pooled survival rates exceeding 90%.

Sickle Cell Disease 59

Sickle Cell Disease Transplant Pediatrics Outcomes 59

Stroke Journal

FEBRUARY 1, 2024

A pediatric neurologist reviewed all records and neuroimaging to verify diagnosis of basilar artery stenosis.Results:Out of our cohort of 331 children with moyamoya, 24 (7.2%) children had basilar artery stenosis. Children with moyamoya and basilar stenosis mentioned in their chart were initially included.

Stenosis 40

Stenosis Sickle Cell Disease Cerebrovascular Disease Pediatrics 40